Lentiviral vectors as a gene delivery system in the mouse midbrain: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF

Experimental Neurology

Volumn 164, Issue 1, 2000, Pages 15-24

  Bensadoun, Jean Charles ^a   Déglon, Nicole ^a   Tseng, Jack L ^a   Ridet, Jean Luc ^a   Zurn, Anne D ^a   Aebischer, Patrick ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Animal model; GDNF; Lentivirus; Midbrain; Mouse; Parkinson's disease

Indexed keywords

6 HYDROXYDOPA; APOMORPHINE; COMPLEMENTARY DNA; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MUTANT PROTEIN; TYROSINE 3 MONOOXYGENASE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL COUNT; CELL DEATH; CELL TYPE; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG SCREENING; GENE TARGETING; GENE THERAPY; GENE TRANSFER; IMMUNOHISTOCHEMISTRY; LENTIVIRINAE; MALE; MESENCEPHALON; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPORTER GENE; SCREENING; SUBSTANTIA NIGRA; VIRUS PARTICLE;

EID: 0343517507     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7409     Document Type: Article

References (40)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:1946;239-247
2. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341
3. Bensadoun J. C., Mirochnitchenko O., Inouye M., Aebischer P., Zurn A. D. Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice. Eur. J. NeuroScience 10:1998;3231-3236
4. Bilang-Bleuel A., Revah F., Colin P., Locquet I., Robert J. J., Mallet J., Horellou P. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc. Natl. Acad. Science USA. 94:1997;8818-8823
5. Blömer U., Naldini L., Kafri T., Trono D., Verma I. M., Gage F. H. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71:1997;6641-6649
6. Bowenkamp K. E., Hoffman A. F., Gerhardt G. A., Henry M. A., Biddle P. T., Hoffer B. J., Granholm A. C. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355:1995;479-489
7. Choi-Lundberg D. L., Lin Q., Chang Y. N., Chiang Y. L., Hay C. M., Mohajeri H., Davidson B. L., Bohn M. C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 275:1997;838-841
8. Choi-Lundberg D. L., Lin Q., Schallert T., Crippens D., Davidson B. L., Chang Y. N., Chiang Y. W. L., Qian J. A., Bardwaj L., Bohn M. C. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Exp. Neurol. 154:1998;261-275
9. Dull T., Zufferey R., Kelly M., Mandel R. J., Nguyen M., Trono D., Naldini L. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:1998;8463-8471
10. Déglon N., Tseng J. L., Bensadoun J. C., Zurn A. D., Arsenijevic Y., Pereira de almeida L., Zufferey R., Trono D., Aebischer P. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum. Gene Ther. 11:2000;179-190
11. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., Mcconlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 373:1995;523-527
12. Gash D. M., Zhang Z., Ovadia A., Cass W. A., Yi A., Simmerman L. R., Russell D., Martin D., Lapchak P. A., Collins F., Hoffer B. J., Gerhardt G. A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255
13. Gurney M. E., Pu H., Chiu A. Y., Dal M. C., Polchow C. Y., Alexander D. D., Caliendo J., Hentati A., Deng H-X., Chen W., Zhai P., Sufit R. L., Siddique T. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 264:1994;1772-1775
14. Hodgson J. G., Agopyan N., Gutekunst C. A., Leavitt B. R., Lepiane F., Singaraja R., Smith D. J., Bissada N., Mccutcheon K., Nasir J., Jamot L., Li X. J., Stevens M. E., Rosemond E., Roder J. C., Phillips A. G., Rubin E. M., Hersch S. M., Hayden M. R. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron. 23:1999;181-192
15. Hoffer B. J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L. F., Gerhardt G. A. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. NeuroScience Lett. 182:1994;107-111
16. Hoffman A. F., Van Horne C. G., Eken S., Hoffer B. J., Gerhardt G. A. In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF. Exp. Neurol. 147:1997;130-141
17. Kearns C. M., Gash D. M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672:1995;104-111
18. Kim V. N., Mitrophanous K., Kingsman S. M., Kingsman A. J. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72:1998;811-816
19. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392:1998;605-608
20. Kordower J. H., Bloch J., Ma S., Chu Y., Palfi S., Roitberg B., Emborg M., Hantraye P., Déglon N., Aebischer P. Lentiviral gene transfer to the nonhuman primate brain. Exp. Neurol. 160:1999;1-16
21. Lapchak P. A., Araujo D. M., Hilt D. C., Sheng J., Jiao S. S. Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease. Brain Res. 777:1997;153-160
22. Lapchak P. A., Jiao S. S., Miller P. J., Williams L. R., Cummins V., Inouye G., Matheson C. R., Yan Q. Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): Implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases. Cell Tissue Res. 286:1996;179-189
23. Lapchak P. A., Miller P. J., Collins F., Jiao S. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: Comparison of intraventricular and intranigral delivery. Neuroscience. 78:1997;61-72
24. Lee C. S., Sauer H., Björklund A. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat. Neuroscience. 72:1996;641-653
25. Lin L. F., Doherty D. H., Lile J. D., Bektesh S., Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132
26. Mandel R. J., Spratt S. K., Snyder R. O., Leff S. E. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of parkinsons disease in rats. Proc. Natl. Acad. Science USA. 94:1997;14083-14088
27. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S. W., Bates G. P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87:1996;493-506
28. Marsden C. D., Parkes J. D. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet. 1:1976;292-296
29. Miyoshi H., Blömer U., Takahashi M., Gage F. H., Verma I. M. Development of a self-inactivating lentivirus vector. J. Virol. 72:1998;8150-8157
30. Naldini L., Blömer U., Gage F. H., Trono D., Verma I. M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Science USA. 93:1996;11382-11388
31. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 272:1996;263-267
32. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di G., Golbe L. I., Nussbaum R. L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047
33. Sauer H., Rosenblad C., Björklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Science USA. 92:1995;8935-8939
34. Tomac A., Lindqvist E., Lin L-F. H., Ogren S. O., Young D., Hoffer B. J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339
35. Tseng J. L., Baetge E. E., Zurn A. D., Aebischer P. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J. NeuroScience 17:1997;325-333
36. Winkler C., Sauer H., Lee C. S., Björklund A. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J. NeuroScience 16:1996;7206-7215
37. Winkler J., Weiss B. Reversal of supersensitive apomorphine-induced rotational behavior in mice by continuous exposure to apomorphine. J. Pharmacol. Exp. Ther. 238:1986;242-247
38. Zufferey R., Donello J. E., Trono D., Hope T. J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73:1999;2886-2892
39. Zufferey R., Dull T., Mandel R. J., Bukovsky A., Quiroz D., Naldini L., Trono D. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72:1998;9873-9880
40. Zufferey R., Nagy D., Mandel R. J., Naldini L., Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotech. 15:1997;871-875